Compare PTCT & SFBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | SFBS |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.4B |
| IPO Year | 2006 | 2014 |
| Metric | PTCT | SFBS |
|---|---|---|
| Price | $56.37 | $38.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $100.47 | $46.00 |
| AVG Volume (30 Days) | ★ 939.5K | 431.3K |
| Earning Date | 10-29-2026 | 10-19-2026 |
| Dividend Yield | N/A | ★ 1.94% |
| EPS Growth | ★ 264.48 | 21.63 |
| EPS | 0.34 | ★ 2.34 |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $20.23 |
| Revenue Next Year | $8.29 | $8.48 |
| P/E Ratio | $171.44 | ★ $16.72 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $58.15 | $37.51 |
| 52 Week High | $90.87 | $92.08 |
| Indicator | PTCT | SFBS |
|---|---|---|
| Relative Strength Index (RSI) | 33.38 | 32.43 |
| Support Level | N/A | $37.51 |
| Resistance Level | $69.74 | $43.15 |
| Average True Range (ATR) | 2.50 | 1.11 |
| MACD | -0.78 | -0.13 |
| Stochastic Oscillator | 1.01 | 0.64 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary. Through the subsidiary, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.